Información sobre riesgo, prevención, detección, síntomas, diagnosis, tratamiento y apoyo para el cáncer.
Información sobre el tratamiento del cáncer incluyendo quirúrgica, quimioterapia, radioterapia, estudios clínicos, terapia con protón, medicina complementaria avanzadas.
OncoLink se complace en ofrecer una amplia lista de lista completa de los agentes quimioterapéuticos más comúnmente usados??. Esta guía de referencia incluye información sobre la forma en que cada fármaco se administra, cómo funcionan, y los pacientes los efectos secundarios comunes pueden experimentar.
Maneras que los pacientes de cáncer y las personas que le cuidan puedan enfrentar el cáncer, los efectos secundarios, nutrición, cuestiones en general sobre el apoyo para el cáncer, duelo/decisiones sobre el termino de vida, y experiencias compartidas por sobrevivientes.
Preguntas más frecuentes / Opciones para el Tratamiento / Radioterapia
Ultima Vez Modificado: 29 de octubre del 2008
![]()
Dear OncoLink "Ask The Experts,"
If someone is receiving internal radiation therapy (brachytherapy) for cervical cancer treatment, is she emitting rays that would affect other people? Is it safe for the patient to be close to a baby?
![]()
Neha Vapiwala , MD, Senior Editor of OncoLink and Chief Resident in the Department of Radiation Oncology at the Hospital of the University of Pennsylvania, responds:
The answer to this question depends upon the type of brachytherapy for cervical cancer that a person is receiving. Brachytherapy can be done as an outpatient procedure, such as with high-dose rate (HDR) therapy, or as an inpatient, which is typically low-dose rate (LDR) therapy. Both HDR and LDR can be used in the management of gynecologic malignancies.
HDR therapy means that a high dose of radiation is given over a relatively brief period of time, as compared with LDR, (low dose rate), in which the radiation is usually delivered over a day or two.
HDR is given by inserting a probe, also called an applicator, into the vagina. This probe is connected to a machine that safely houses a radiation source. The machine automatically feeds the radiation source into the probe, where it remains for a predetermined time, known as the dwell time (typically 10-20 minutes). Once the time is up, the machine retracts the radiation source and the vaginal applicator is removed. As soon as the applicator is removed, the patient does not give off any radiation or emit any radioactivity. She is sent home and does not pose a risk to anyone around her. This procedure is typically repeated several times over a period of weeks.
When LDR brachytherapy is given, it is done so over several days, with the patient staying in the hospital for that period of time. An applicator is inserted into the vaginal or uterine cavity. The radiation source is inserted into the applicator and remains there for several days. During this time, the patient stays in a special lead-lined room. In the hospital room, large lead-lined portable shields are used to protect those who will enter the room to care for the patient (i.e. they will stand behind the shield whenever possible). In order to protect anyone who enters the room from radiation exposure, one should follow the principles of time and distance. In other words, stay for as short a time as possible when in closer proximity to the patient, and/or stay longer but remain as far away as possible from the patient. Visitors are encouraged to not visit in person, but call on the phone. Contact with infants and pregnant women is strongly discouraged.
When the treatment is complete, the radiation sources and applicator are removed, and the patient is discharged home. As with HDR, a patient is not sent home with radiation sources in her body, so she is not emitting any radiation at that point, and it is safe for people, including infants and pregnant women, to be around them.
Donna Lee shares how it feels to have cancer and what others can do to help. Read more.
Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet
Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy
Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies
Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer
Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults
OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews
Ask the Experts
Brown Bag Chat
Tracy's Corner
About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement
Calcium Leucovorin, Citrovorum Factor, Folinic Acid
Cladribine (2-CDA, Leustatin®)
Cyclophosphamide (Cytoxan®, Neosar®, Endoxan®)
Cyclosporine (Neoral®, Sandimmune®, Restasis®, Gengraf®)
Cytarabine (Cytosar-U®, Ara-C)
Irinotecan (Camptosar®, CPT-11)
Leucovorin (Calcium Leucovorin, Citrovorum Factor, Folinic Acid)
Calcium Leucovorin, Citrovorum Factor, Folinic Acid
Leucovorin (Calcium Leucovorin, Citrovorum Factor, Folinic Acid)
Leuprolide Acetate (Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®) - For Men
Leuprolide Acetate (Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®) - For Women
Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®
Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®
Busulfan (Myleran®, Busulfex®)
Intravesicular Mitomycin (Mutamycin®, Mitomycin-C, given into the bladder)
Mechlorethamine (Mustargen®, Nitrogen Mustard)
mechlorethamine, mustine, Mustargen®
Megestrol (Megace®, Megace-ES®)
Mercaptopurine (Purinethol®, 6-MP)
Methotrexate (Mexate®, Folex®, Rheumatrex®, Amethopterin, MTX)
Mexate®, Folex®, Rheumatrex®, Amethopterin, MTX
Mitomycin (Mutamycin®, Mitomycin-C)
Morphine Sulfate (Given by IV)
Morphine Sulfate (MS Contin®, Avinza®, Kadian®, Oramorph SR®)
MS Contin®, Avinza®, Kadian®, Oramorph SR®
Mutamycin®, Mitomycin-C, given into the bladder
Nitrogen mustard (mechlorethamine, mustine, Mustargen®)
Bendamustine Hydrochloride (Treanda®)
Bexarotene (Targretin®), Oral Formulation
Bexarotene Gel (Targretin® Gel Formulation)
Etoposide (Toposar®, VePesid®, Etopophos®,VP-16)
Thioguanine (6-TG, Thioguanine Tabloid®)
Toposar®, VePesid®, Etopophos®,VP-16
Trelstar LA® and Trelstar Depot®
Tretinoin (Vesanoid®, All-Trans-Retinoic Acid, ATRA)
Triptorelin (Trelstar LA® and Trelstar Depot®)

